XML 20 R7.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Beginning balance, value at Jan. 25, 2020 $ 868,604 $ 10,528 $ 30,158 $ (1,781) $ 829,699  
Beginning balance, shares at Jan. 25, 2020   31,583,938        
Increase (Decrease) in Stockholders' Equity            
Stock options exercised, value 5,738 $ 98 5,640      
Stock options exercised, shares   295,650        
Stock-based compensation 12,771 $ 1 12,770      
Stock-based compensation, shares   4,962        
Issuance of restricted stock, net of tax withholdings (728) $ 19 (747)   0  
Issuance of restricted stock, net of tax withholdings, shares   54,998        
Equity component of the settlement of $0.75% convertible senior notes due 2021, net of taxes (8,976)   (8,976)      
Purchase of warrants (7,176)   (7,176)      
Settlement of convertible note hedges related to extinguishment of convertible debt 7,197   7,197      
Repurchase of common stock, value (100,000) $ (441) (36,582)   (62,977)  
Repurchase of common stock, shares   (1,324,381)        
Other comprehensive income (loss)       12    
Net Income 34,337       34,337  
Ending balance, value at Jan. 30, 2021 $ 811,308 $ 10,205 2,284 (1,769) 800,588 $ (471)
Ending balance, shares at Jan. 30, 2021   30,615,167        
Increase (Decrease) in Stockholders' Equity            
Accounting Standards Update [Extensible Enumeration] Accounting Standards Update 2016-13 [Member]          
Stock options exercised, value $ 2,261 $ 14 2,247      
Stock options exercised, shares   42,580        
Stock-based compensation 9,866 $ 1 9,865      
Stock-based compensation, shares   2,197        
Issuance of restricted stock, net of tax withholdings (6,639) $ 62 (2,767)   (3,934)  
Issuance of restricted stock, net of tax withholdings, shares   184,561        
Purchase of warrants (693)   (693)      
Repurchase of common stock, value (106,133) $ (411) (8,909)   (96,814)  
Repurchase of common stock, shares   (1,231,638)        
Net Income 48,574       48,574  
Ending balance, value at Jan. 29, 2022 $ 758,544 $ 9,871 2,028 (1,769) 748,414  
Ending balance, shares at Jan. 29, 2022 29,612,867 29,612,867        
Increase (Decrease) in Stockholders' Equity            
Stock options exercised, value $ 4,557 $ 40 4,517      
Stock options exercised, shares   119,430        
Stock-based compensation 17,927 $ 1 17,926      
Stock-based compensation, shares   1,824        
Issuance of restricted stock, net of tax withholdings (5,752) $ 43 (3,449)   (2,346)  
Issuance of restricted stock, net of tax withholdings, shares   129,930        
Repurchase of common stock, value (48,732) $ (172) (15,368)   (33,192)  
Repurchase of common stock, shares   (514,030)        
Other comprehensive income (loss) (2)     (2)    
Net Income 142,213       142,213  
Ending balance, value at Jan. 28, 2023 $ 868,755 $ 9,783 $ 5,654 $ (1,771) $ 855,089  
Ending balance, shares at Jan. 28, 2023 29,350,021 29,350,021